Cipla Ltd, a global pharmaceutical company, has announced the appointment of Kedar Upadhye as the global chief financial officer of the company effective August 1, 2016.
Kedar is a qualified cost accountant with a follow-on MBA from IIM Bangalore. He brings with him deep experience of the global generics business. Until recently, Kedar was vice president, global generics finance and head of investor relations in Dr Reddy’s. Prior to Dr Reddy’s, he has worked with Pepsi India and Thermax Group.
Commenting on his appointment, Subhanu Saxena, MD and Global CEO, Cipla Ltd said, “We are pleased to welcome Kedar Upadhye to Cipla’s leadership team. With his strong financial expertise and deep insights about the global generics industry, he shall be a strong addition to our Management Council to help us move forward towards our aspirations.”
With Kedar joining Cipla and assuming the responsibility of Global CFO, Umang Vohra will cease to be the Global CFO of the company. Umang will continue to be the global chief operating officer.